Press release from Business Wire
Investor Alert: Former Louisiana Attorney General and Kahn Swick & Foti, LLC, Remind Investors with Large Financial Interests of Lead Plaintiff Deadline in Class Action Lawsuit Against ViroPharma Inc.
Saturday, May 19, 2012
Investor Alert: Former Louisiana Attorney General and Kahn Swick & Foti, LLC, Remind Investors with Large Financial Interests of Lead Plaintiff Deadline in Class Action Lawsuit Against ViroPharma Inc.11:53 EDT Saturday, May 19, 2012 NEW ORLEANS (Business Wire) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 17, 2012, to file lead plaintiff applications in a securities class action lawsuit against ViroPharma Inc. (Nasdaq:VPHM - News), if they purchased the Company's securities during the period between December 14, 2011 and April 9, 2012, inclusive (the "Class Period"). This action is pending in the United States District Court for the Eastern District of Pennsylvania. What You May Do If you purchased shares of ViroPharma and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, e-mail or call KSF Managing Partner, Lewis Kahn (email@example.com), toll free, 877-515-1850, or via cell phone any time at 504-301-7900, or KSF Director of Client Relations, Neil Rothstein, Esq. (firstname.lastname@example.org), toll free at 877-694-9510, or via cell phone any time at 330-860-4092. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by July 17, 2012. About the Lawsuit ViroPharma and certain of its senior executives are charged with issuing a series of materially false and misleading statements, during the Class Period, in violation of federal securities laws. On April 10, 2012, shares of ViroPharma common stock dropped $6.17, closing at $22.44 per share, after the Company announced that the FDA would not grant additional exclusivity for its drug Vancocin. This announcement stood in stark contrast to the representations made previously by the Company. About Kahn Swick & Foti, LLC To learn more about KSF, whose partners include the Former Louisiana Attorney General, Charles C. Foti, Jr., and other lawyers with significant experience litigating complex securities class actions nationwide on behalf of both institutional and individual shareholders, you may visit www.ksfcounsel.com. Kahn Swick & Foti, LLCLewis Kahn, Managing Partner, 877-515-1850or after hours via cell phone email@example.com